DLG3
Basic information
Region (hg38): X:70444835-70505490
Links
Phenotypes
GenCC
Source:
- intellectual disability, X-linked 90 (Definitive), mode of inheritance: XLR
- intellectual disability, X-linked 90 (Strong), mode of inheritance: XL
- non-syndromic X-linked intellectual disability (Supportive), mode of inheritance: XL
- intellectual disability, X-linked 90 (Definitive), mode of inheritance: XL
- non-syndromic X-linked intellectual disability (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, X-linked 90 | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 15185169; 24721225 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- Inborn genetic diseases (3 variants)
- Intellectual disability, X-linked 90 (2 variants)
- Intellectual disability (2 variants)
- DLG3-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DLG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 30 | ||||
missense | 78 | 84 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 5 | 2 | 7 | |||
non coding | 17 | 24 | ||||
Total | 10 | 9 | 88 | 30 | 21 |
Variants in DLG3
This is a list of pathogenic ClinVar variants found in the DLG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-70445188-C-CG | Intellectual disability, X-linked 90 | Pathogenic (May 25, 2016) | ||
X-70445206-A-C | Intellectual disability, X-linked 90 • Inborn genetic diseases | Uncertain significance (Aug 17, 2021) | ||
X-70445224-G-A | Uncertain significance (Feb 13, 2024) | |||
X-70445230-G-A | Uncertain significance (Dec 15, 2023) | |||
X-70445243-T-G | Likely pathogenic (Jun 11, 2019) | |||
X-70445249-G-C | Inborn genetic diseases | Likely benign (Jun 20, 2018) | ||
X-70445258-G-C | Intellectual disability, X-linked 90 | Uncertain significance (Jun 14, 2024) | ||
X-70445266-T-C | Uncertain significance (Jun 24, 2022) | |||
X-70445276-C-G | Likely benign (Jun 01, 2024) | |||
X-70445283-C-A | not specified • Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
X-70445292-G-A | Inborn genetic diseases | Likely benign (Oct 29, 2021) | ||
X-70445294-C-T | Benign (Dec 31, 2019) | |||
X-70445295-G-A | not specified | Uncertain significance (Aug 25, 2017) | ||
X-70445297-C-T | Likely benign (Aug 01, 2022) | |||
X-70445301-C-T | Pathogenic (Feb 22, 2023) | |||
X-70445309-C-T | Likely benign (Jun 01, 2022) | |||
X-70445316-T-TA | Intellectual disability, X-linked 90 | Likely pathogenic (Aug 23, 2023) | ||
X-70445325-G-A | Uncertain significance (Jun 17, 2024) | |||
X-70445326-G-GT | not provided (-) | |||
X-70445327-T-A | not specified | Likely benign (Apr 09, 2018) | ||
X-70445328-G-A | Intellectual disability, X-linked 90 | Uncertain significance (Jul 02, 2020) | ||
X-70445329-G-T | Inborn genetic diseases | Uncertain significance (Mar 30, 2020) | ||
X-70445350-G-C | Inborn genetic diseases | Uncertain significance (Oct 06, 2022) | ||
X-70445353-A-C | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
X-70445354-TG-T | Inborn genetic diseases | Pathogenic (May 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DLG3 | protein_coding | protein_coding | ENST00000374360 | 19 | 60627 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000703 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.88 | 186 | 334 | 0.557 | 0.0000262 | 5330 |
Missense in Polyphen | 21 | 44.716 | 0.46963 | 713 | ||
Synonymous | 0.697 | 124 | 134 | 0.924 | 0.0000109 | 1591 |
Loss of Function | 5.35 | 0 | 33.3 | 0.00 | 0.00000283 | 484 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for learning most likely through its role in synaptic plasticity following NMDA receptor signaling.;
- Disease
- DISEASE: Mental retardation, X-linked 90 (MRX90) [MIM:300850]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non- syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. {ECO:0000269|PubMed:15185169}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Tight junction - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Developmental Biology;Activation of Ca-permeable Kainate Receptor;Ionotropic activity of kainate receptors;Activation of kainate receptors upon glutamate binding;Fibroblast growth factor-1;NrCAM interactions;Neuronal System;Synaptic adhesion-like molecules;EGFR1;Neurexins and neuroligins;L1CAM interactions;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Axon guidance;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.342
Intolerance Scores
- loftool
- 0.0977
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.99
Haploinsufficiency Scores
- pHI
- 0.999
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.704
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dlg3
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype;
Gene ontology
- Biological process
- MAPK cascade;establishment of planar polarity;chemical synaptic transmission;negative regulation of cell population proliferation;negative regulation of phosphatase activity;receptor clustering;establishment or maintenance of epithelial cell apical/basal polarity;positive regulation of protein tyrosine kinase activity;receptor localization to synapse;cell-cell adhesion;regulation of postsynaptic membrane neurotransmitter receptor levels;maintenance of postsynaptic density structure
- Cellular component
- extracellular space;cytosol;plasma membrane;bicellular tight junction;ionotropic glutamate receptor complex;basolateral plasma membrane;cell junction;growth cone;neuromuscular junction;AMPA glutamate receptor complex;neuron projection;neuronal cell body;dendritic shaft;postsynaptic density membrane;glutamatergic synapse;postsynaptic density, intracellular component
- Molecular function
- Ras guanyl-nucleotide exchange factor activity;protein binding;protein C-terminus binding;kinase binding;phosphatase binding;protein phosphatase binding;PDZ domain binding;ubiquitin protein ligase binding;ionotropic glutamate receptor binding;structural constituent of postsynaptic density